Department of Physiology, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
RVM Institute of Medical Sciences, Siddipet, Hyderabad, Telangana, India.
Horm Mol Biol Clin Investig. 2022 Sep 5;44(1):89-96. doi: 10.1515/hmbci-2022-0010. eCollection 2023 Mar 1.
COVID-19 emerged in Wuhan, China, but was caused by the original coronavirus, severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV2). In early 2020, there was a widespread breakout of cases well over world, resulting in an epidemic that rapidly escalated to become a pandemic. This abruptly shook the global healthcare system. The emergence of the alpha, beta, and delta SARS-CoV-2 were associated with new waves of infections, sometimes across the entire world but until this month i.e., between Nov-Dec, 2021, Delta variant reigned supreme until the emergence of a newer variant i.e., Omicron (B.1.1.529) of SARS-CoV-2. Delta had 13 mutations. Of these, nine are in the spike protein, the protrusion on the surface of the virus that helps it latch onto human cells. Specifically, two are in a molecular hook, called the "receptor-binding domain". Omicron, a creation caused by monstrous mutations. At least 32 mutations are in the spike protein and 10 in the receptor-binding domain. was designated a COVID-19 variant of concern (VoC) by the World Health Organization (WHO) on 26th November 2021. Structurally, the omicron variant has shown too mutated at antibody binding sites which would leverage them for escaping the possible immune response by the body. We don't yet know much about the other alterations and how they might affect the virus's behavior. Omicron COVID-19 strain after identifying individuals with symptoms that were not the same as those seen in the Delta form. People with night sweats have also been reported. The new omicron variant has more mutations than the prevailing rampant delta virus. This makes the newer variant more transmissible, better able to evade itself from various vaccines readily available in the current scenario. These overall increases in the percentage changes in a single day cases of COVID-19 reported cases can be attributed to the beginning of third wave or can be speculated as newer surge of omicron variant cases. Yet another new variant has been detected in France with 46 mutations and 37 deletions in its genetic code, many affecting the spike protein. 'B.1.640.2' is the current nomenclature for this variation.
新冠病毒(COVID-19)最初在中国武汉出现,但它是由原始冠状病毒,即严重急性呼吸系统综合征相关冠状病毒-2(SARS-CoV-2)引起的。2020 年初,该病毒在世界范围内广泛爆发,导致疫情迅速升级成为全球大流行。这突然撼动了全球医疗保健系统。阿尔法、贝塔和德尔塔 SARS-CoV-2 的出现与新的感染浪潮有关,有时甚至在全球范围内,但直到本月(即 2021 年 11 月至 12 月),德尔塔变体一直占据主导地位,直到一种新的变体即奥密克戎(B.1.1.529)的出现。德尔塔变体有 13 处突变。其中 9 处位于病毒表面的刺突蛋白上,该蛋白帮助病毒附着在人类细胞上。具体来说,有两处突变位于分子钩上,称为“受体结合域”。奥密克戎是由可怕突变造成的一种新变体。刺突蛋白上至少有 32 处突变,受体结合域中有 10 处突变。2021 年 11 月 26 日,世界卫生组织(WHO)将其指定为关注的 COVID-19 变体(VOC)。在结构上,奥密克戎变体在抗体结合位点上发生了太多突变,这使得它能够逃避身体可能产生的免疫反应。我们目前还不太了解其他的变化,以及它们可能如何影响病毒的行为。在识别出与德尔塔形式不同的症状的个体后,发现了奥密克戎 COVID-19 株。也有报道称出现夜间出汗的人。新的奥密克戎变体比目前流行的猖獗的德尔塔病毒有更多的突变。这使得新变体更具传染性,更能逃避当前情况下各种现有疫苗的作用。在 COVID-19 报告病例中,每天病例百分比变化的这些总体增加可以归因于第三波疫情的开始,也可以推测为奥密克戎变体病例的新激增。在法国又检测到了另一种新变体,其基因密码中有 46 处突变和 37 处缺失,其中许多影响刺突蛋白。目前这种变体的命名为“B.1.640.2”。